Life Sciences
Life Sciences transactions advisory services
Executing on the investment strategy
In today's market, the life sciences companies that can define a clear strategy, deploy capital effectively against that strategy and continue to innovate will win. Having the right advisors who understand your investment strategy, know your team, have the relevant transaction skills and industry knowledge and are ready when you are can help make the difference.
How we can help
The Life Sciences Capital Agenda framework helps connect your overall capital strategy to our services as you focus on the cornerstones of preserving, optimizing, investing and raising capital. It also helps you consider capital options throughout the economic cycle. Choosing the right options will help you make the decisions needed to succeed in today's environment where volatility is the only constant.
Our transaction professionals understand and can help you execute the increasingly innovative transactions that are redefining the life sciences industry.
Contact us
 | Lara Iob Leader, Life Sciences 514 879 6514 |
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
Disruptors: Revolutionizing Drug/Dx Reimbursement
11-12 March 2013
Philadelphia, Pennsylvania (US)
Join us at this premier event which brings together senior executives from leading product (pharma, medtech, biotech) companies along with payers, providers and policymakers to discuss the key issues that will set the product reimbursement agenda over the next few years.
